B.M.P. PHARMA TRAD (BMP.SG) (BMP) - Total Assets
Based on the latest financial reports, B.M.P. PHARMA TRAD (BMP.SG) (BMP) holds total assets worth €12.67 Million EUR (≈ $14.81 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
B.M.P. PHARMA TRAD (BMP.SG) - Total Assets Trend (2013–2025)
This chart illustrates how B.M.P. PHARMA TRAD (BMP.SG)'s total assets have evolved over time, based on quarterly financial data. Also see BMP stock market capitalisation for the company's overall valuation and market capitalisation.
B.M.P. PHARMA TRAD (BMP.SG) - Asset Composition Analysis
Current Asset Composition (December 2025)
B.M.P. PHARMA TRAD (BMP.SG)'s total assets of €12.67 Million consist of 63.9% current assets and 36.1% non-current assets. Review total liabilities of B.M.P. PHARMA TRAD (BMP.SG) to assess the company's total debt and financial obligations.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0.4% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2013–2025)
This chart illustrates how B.M.P. PHARMA TRAD (BMP.SG)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See BMP stock price and chart for real-time trading data and today's change.
Key Asset Composition Facts
- Current vs. Non-Current Assets: B.M.P. PHARMA TRAD (BMP.SG)'s current assets represent 63.9% of total assets in 2025, an increase from 17.3% in 2013.
- Cash Position: Cash and equivalents constituted 0.4% of total assets in 2025, up from 0.1% in 2013.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2013.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
B.M.P. PHARMA TRAD (BMP.SG) Competitors by Total Assets
Key competitors of B.M.P. PHARMA TRAD (BMP.SG) based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADVANCED INF SERV(ADVANC)
STU:NVAA
|
Belgium | €401.79 Billion |
|
OPG POWER VENTURES (OPB.SG)
STU:OPB
|
Germany | €229.47 Million |
|
SY PUBLIC UTIL -H- (SH3.SG)
STU:SH3
|
Germany | €373.72 Million |
|
Novae Group Plc
STU:NVAL
|
Germany | €1.03 Trillion |
|
AMUR MINERALS (A7L.SG)
STU:A7L
|
Germany | €1.80 Million |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Copa Holdings S.A
F:C2H
|
Germany | €6.58 Billion |
|
TRELLUS HEALTH LS -0006
F:85Q
|
Germany | €9.22 Million |
B.M.P. PHARMA TRAD (BMP.SG) - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 19.67 | 53.49 | 12.71 |
| Quick Ratio | 19.67 | 53.49 | 12.71 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €7.68 Million | €8.30 Million | €1.80 Million |
B.M.P. PHARMA TRAD (BMP.SG) - Advanced Valuation Insights
This section examines the relationship between B.M.P. PHARMA TRAD (BMP.SG)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.95 |
| Latest Market Cap to Assets Ratio | 2.49 |
| Asset Growth Rate (YoY) | -5.7% |
| Total Assets | €12.67 Million |
| Market Capitalization | $31.50 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values B.M.P. PHARMA TRAD (BMP.SG)'s assets at a significant premium (2.49x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: B.M.P. PHARMA TRAD (BMP.SG)'s assets decreased by 5.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for B.M.P. PHARMA TRAD (BMP.SG) (2013–2025)
The table below shows the annual total assets of B.M.P. PHARMA TRAD (BMP.SG) from 2013 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | €12.67 Million ≈ $14.81 Million |
-5.69% |
| 2024-12-31 | €13.43 Million ≈ $15.70 Million |
+10.82% |
| 2023-12-31 | €12.12 Million ≈ $14.17 Million |
-1.37% |
| 2022-12-31 | €12.29 Million ≈ $14.37 Million |
+25.10% |
| 2021-12-31 | €9.82 Million ≈ $11.48 Million |
+41.85% |
| 2020-12-31 | €6.92 Million ≈ $8.10 Million |
+8.40% |
| 2019-12-31 | €6.39 Million ≈ $7.47 Million |
+6.13% |
| 2018-12-31 | €6.02 Million ≈ $7.04 Million |
+8.48% |
| 2017-12-31 | €5.55 Million ≈ $6.49 Million |
+1.34% |
| 2016-12-31 | €5.48 Million ≈ $6.40 Million |
+1.55% |
| 2015-12-31 | €5.39 Million ≈ $6.30 Million |
+9.50% |
| 2014-12-31 | €4.92 Million ≈ $5.76 Million |
+0.31% |
| 2013-12-31 | €4.91 Million ≈ $5.74 Million |
-- |
About B.M.P. PHARMA TRAD (BMP.SG)
There is no Profile data available for BMP.SG.